Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ventricular resynchronization: a promising therapy for heart failure.

Uday N Kumar1, Leslie A Saxon

  • 1Division of Cardiology, University of California at San Francisco, San Francisco, CA 94143-0001, USA.

The American Journal of Geriatric Cardiology
|December 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest.

Journal of the American College of Cardiology·2024
Same author

First human safety and effectiveness study of defibrillation with a novel patch wearable cardioverter-defibrillator.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2024
Same author

Force plate assessments in reconnaissance marine training company.

BMC sports science, medicine & rehabilitation·2024
Same author

Player Tracking Technology and Data for Injury Prevention in the National Football League.

Current sports medicine reports·2021
Same author

The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy.

JACC. Heart failure·2021
Same author

Home Monitoring of Cardiac Devices in the Era of COVID-19.

Current cardiology reports·2020

Ventricular resynchronization therapy offers a promising device-based approach for heart failure patients with persistent symptoms. This therapy addresses ventricular dyssynchrony, improving cardiac function and remodeling.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Heart failure is a growing concern, particularly in the elderly population.
  • Pharmacological treatments remain insufficient for a significant number of heart failure patients.
  • Device therapies are being explored to manage persistent heart failure symptoms.

Purpose of the Study:

  • To review ventricular resynchronization therapy (VRT) for heart failure.
  • To discuss the significance of ventricular dyssynchrony.
  • To explore the role of VRT in improving cardiac function and remodeling.

Main Methods:

  • Review of current literature on ventricular resynchronization therapy.
  • Analysis of clinical trial data on VRT efficacy.

Related Experiment Videos

  • Discussion of accepted indications for resynchronization devices.

    • Main Results:

    • Ventricular dyssynchrony is a key factor in heart failure progression.
    • Ventricular resynchronization therapy can improve contractile function.
    • Reverse remodeling is a documented effect of VRT in select patients.

    Conclusions:

    • Ventricular resynchronization therapy is a promising treatment modality for heart failure.
    • Understanding ventricular dyssynchrony is crucial for patient selection.
    • Ongoing trials continue to define the optimal use of VRT.